Search results
Jan 1, 2022 · Dominik Paul Modest 1 2 , Meinolf Karthaus 3 , Stefan Fruehauf 4 , Ullrich Graeven 5 , Lothar Müller 6 , Alexander Otto König 7 , Ludwig Fischer von Weikersthal 8 , Karel Caca 9 , Albrecht Kretzschmar 10 , Eray Goekkurt 11 12 , Siegfried Haas 13 , Annika Kurreck 1 , Arndt Stahler 1 , Swantje Held 14 , Armin Jarosch 14 , David Horst 2 14 ...
Jul 12, 2021 · Background Longer-term consequences after SARS-CoV-2 infection are becoming an important burden to societies and healthcare systems. Data on post-COVID-19 syndrome in the general population are required for the timely planning of healthcare services and resources. The objective of this study was to assess the prevalence of impaired health status and physical and mental health symptoms among ...
Jul 12, 2021 · In this population-based study, a relevant proportion of participants suffered from longer-term consequences after SARS-CoV-2 infection. With millions infected across the world, our findings emphasize the need for the timely planning of resources and patient-centered services for post-COVID-19 care.
Feb 5, 2021 · Mechanical resonators based on silicon nitride membranes offer very high quality factors and outstanding force sensitivity. However, applying such devices as practical sensors has long been impeded by their seemingly incompatible clamping geometry. Using an unconventional setup, the authors realize a membrane-based scanning force microscope and demonstrate nanometer-scale topographic imaging ...
David Jonietz In Sarjakoski T, et al. [Eds.]: Geospatial Data in a Changing World, Lecture Notes in Geoinformation and Cartography, 279 – 295, (2016) Springer. Location-based User Profiling for Personalized Mobility Support (Poster) David Jonietz, Dominik Bucher, Martin Raubal 3rd Annual Conference SCCER Mobility 2016, Zurich, Switzerland ...
Jun 1, 2021 · Aims: To quantify the arousal burden (AB) across large cohort studies and determine its association with long-term cardiovascular (CV) and overall mortality in men and women.
These findings provide novel mechanistic insights into how myeloid and T cells can be uniquely modulated by the dual innate and adaptive checkpoint antibody and demonstrate its potential in clinical development (NCT04881045) to improve patient outcomes over current PD-(L)1 and CD47-targeted therapie …
